Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
OPINION
8 Stocks Under $10 Making Big Moves Higher
By Roberto Pedone
Nov 13, 2015 9:27 AM EST
PRESS RELEASES
Oragenics Announces Recent Capital Raise And Warrant Exercises Totaling $21.9 Million And The Redemption Of Its Series C Preferred Stock
By Business Wire
Feb 12, 2021 8:00 AM EST
PRESS RELEASES
Gray Dashed Line = P<0.05 Gray Solid Line = P<0.01 (Graphic: Business Wire)
By Business Wire
Feb 2, 2021 8:00 AM EST
PRESS RELEASES
Oragenics Issues Letter To Stockholders
By Business Wire
Jan 14, 2021 7:00 AM EST
PRESS RELEASES
Oragenics Announces Closing Of $6.5 Million Registered Direct Offering
By Business Wire
Dec 29, 2020 4:00 PM EST
PRESS RELEASES
Oragenics, Inc. Announces $6.5 Million Registered Direct Offering
By Business Wire
Dec 24, 2020 8:30 AM EST
PRESS RELEASES
Oragenics Announces Closing Of $6.0 Million Underwritten Public Offering
By Business Wire
Nov 24, 2020 11:37 AM EST
PRESS RELEASES
Oragenics Prices $5.25 Million Common Stock Offering
By Business Wire
Nov 20, 2020 8:30 AM EST
PRESS RELEASES
Organics Announces Proposed Underwritten Public Offering
By Business Wire
Nov 19, 2020 4:22 PM EST
PRESS RELEASES
FDA Broadly Supports Oragenics' Pre-IND Development Program For Its SARS-CoV-2 Vaccine
By Business Wire
Oct 6, 2020 7:30 AM EDT
PRESS RELEASES
Oragenics Provides An Update On Funding For Its SARS-CoV-2 Vaccine
By Business Wire
Sep 28, 2020 7:30 AM EDT
PRESS RELEASES
Oragenics Inc. To Present At The H.C. Wainwright 22nd Annual Global Virtual Investment Conference
By Business Wire
Sep 11, 2020 7:30 AM EDT
PRESS RELEASES
Oragenics Signs Process Development And Manufacturing Agreement With Avid Bioservices For Coronavirus Vaccine
By Business Wire
Aug 20, 2020 8:30 AM EDT
PRESS RELEASES
Preclinical Study Shows SARS-CoV-2 Spike Protein Licensed By Oragenics From The NIH Produces Neutralizing Antibodies
By Business Wire
Jul 22, 2020 7:30 AM EDT
PRESS RELEASES
Oragenics Provides Update On SARS-CoV-2 (COVID-19) Program
By Business Wire
Jul 10, 2020 7:30 AM EDT
PRESS RELEASES
Oragenics, Inc. To Present At The June 2020 Virtual Summer Investor Summit
By Business Wire
Jun 4, 2020 8:00 AM EDT
PRESS RELEASES
Oragenics Inc. And Aragen Bioscience Enter Agreement To Accelerate Development Of TerraCoV2, A SARS-CoV-2 (COVID 19) Vaccine Candidate
By Business Wire
May 19, 2020 8:01 AM EDT
PRESS RELEASES
Oragenics Announces New Member Of The Board Of Directors
By Business Wire
May 4, 2020 6:15 AM EDT
PRESS RELEASES
Oragenics Acquires Noachis Terra Inc., To Develop Its TerraCoV2 NIH-Generated SARS-CoV-2 (COVID 19) Vaccine Candidate Utilizing "Spike Protein"
By Business Wire
May 4, 2020 6:00 AM EDT
PRESS RELEASES
Oragenics, Inc. Announces Early Top-Line Results Of Phase 2 Clinical Trial Of AG013 For Oral Mucositis In Chemoradiation Treatment Of Head And Neck Cancer
By Business Wire
Apr 15, 2020 6:30 AM EDT
PRESS RELEASES
Oragenics, Inc. To Present At The 22nd Annual BIO CEO & Investor Conference
By Business Wire
Feb 7, 2020 10:24 AM EST
PRESS RELEASES
Oragenics Inc. To Present At The LD Micro 12th Annual Main Event On December 10, 2019
By Business Wire
Dec 3, 2019 3:30 AM EST
OPINION
8 Stocks Under $10 Making Big Moves Higher
By Roberto Pedone
Nov 13, 2015 9:27 AM EST
MARKETS
Oragenics (OGEN) Is Today's Strong On High Volume Stock
By TheStreet Wire
Aug 6, 2015 10:04 AM EDT
OPINION
5 Stocks Poised for Breakouts
By Roberto Pedone
Jul 24, 2015 12:13 PM EDT
